|
Status |
Public on Mar 27, 2024 |
Title |
Human-Specific Elimination of Epithelial Siglec-XII Suppresses the Risk of CRC Initiation and Progression |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
38990656 |
|
Submission date |
Mar 20, 2024 |
Last update date |
Sep 27, 2024 |
Contact name |
Pradipta Ghosh |
E-mail(s) |
prghosh@ucsd.edu
|
Organization name |
University of California San Diego
|
Department |
Departments of Medicine and Cellular and Molecular Medicine
|
Street address |
9500 Gilman Drive (MC 0651)
|
City |
La Jolla, CA 92093 |
State/province |
CA |
ZIP/Postal code |
92093 |
Country |
USA |
|
|
Platforms (2) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (21)
|
GSM8157285 |
Caco-2_pCDNA_3_1-Empty_Vector_4_S76 |
GSM8157286 |
Caco-2_pCDNA_3_1-Siglec12_1_S77 |
GSM8157287 |
Caco-2_pCDNA_3_1-Siglec12_2_S78 |
GSM8157288 |
Caco-2_pCDNA_3_1-Siglec12_3_S79 |
GSM8157289 |
Caco-2_pCDNA_3_1-Siglec12_4_S80 |
GSM8157290 |
Colon, Control_1_S57 |
GSM8157291 |
Colon, Control_2_S58 |
GSM8157292 |
Colon, Control_3_S59 |
GSM8157293 |
Colon, Control_4_S60 |
GSM8157294 |
Colon, SiglecXII_1_S61 |
GSM8157295 |
Colon, SiglecXII_2_S62 |
GSM8157296 |
Colon, SiglecXII_3_S63 |
GSM8157297 |
Colon, SiglecXII_4_S64 |
GSM8157298 |
Colon, Control_1_S67 |
GSM8157299 |
Colon, Control_4_S69 |
GSM8157300 |
Colon, SiglecXII_2_S71 |
GSM8157301 |
Colon, SiglecXII_3_S72 |
GSM8157302 |
Colon, SiglecXII_4_S73 |
|
This SuperSeries is composed of the following SubSeries: |
GSE262085 |
Human-Specific Elimination of Epithelial Siglec-XII Suppresses the Risk of CRC Initiation and Progression [CACO] |
GSE262086 |
Human-Specific Elimination of Epithelial Siglec-XII Suppresses the Risk of CRC Initiation and Progression [baseline] |
GSE262087 |
Human-Specific Elimination of Epithelial Siglec-XII Suppresses the Risk of CRC Initiation and Progression [ENDPOINT] |
|
Relations |
BioProject |
PRJNA1090166 |